Zoom Communications, Inc. (ZM)

Zoom Communications, Inc. (ZM) is trading in the middle of its 52-week range and below all of its key moving averages, while the stock sits at a steep discount to sector valuation. The stock closed down 0.87% in the latest session on volume 30.7% above its average. Analysts remain positive, with 19 of 30 rating it Buy, but the share price has not followed that stance. Over the past year the stock is up 9.32%, yet it is down 14.28% over three months, so the debate is between a cheap multiple and weak recent price action.

The stock trades at a trailing P/E of 8.43, against a sector median of 35.1 for the Technology stocks CleaRank tracks, which is 76.0% below that median. On price-to-sales the gap is narrower: 5.31 against a sector median of 7.6, or 30.1% below. Investors pricing the stock this way are asking whether that GAAP figure is durable, because revenue growth is the piece of the story that is lagging.

Revenue grew 4.90% in the latest quarter, year on year, against a sector median of 24.2%, a gap of 19.3 percentage points. Analysts expect revenue to rise 4.6% this fiscal year and earnings per share to rise 3.7%, to $6.14, with a further 3.3% increase to $6.34 next fiscal year. Those are modest rates. The balance sheet and profitability are the strengths: a net profit margin of 65.19%, an operating margin of 24.61%, a return on equity of 32.14% against a sector median of 13.4%, and debt-to-equity of 0.01. The company is highly profitable but not expanding quickly, and the market is pricing it accordingly.

Zoom beat the EPS estimate in seven of the last eight reports, but the share price fell in the first session after four of those beats. The August 25, 2026 report beat by 4.73% at $1.55 against an estimate of $1.48, yet the stock fell 7.03% in the first session after it. The May 21, 2026 beat of 9.15% was followed by a 9.19% rise, and the February 25, 2026 miss of 3.36% by an 11.58% drop. Beats on earnings have not reliably lifted the price, which suggests investors are focused on revenue and guidance rather than the EPS line alone.

Analysts are more constructive than the price: 19 of 30 rate the stock Buy, 10 Hold and 1 Sell, and the median 12-month target is $122.50, 34.7% above the price. In October 2026, Needham and RBC Capital, along with other firms, kept their ratings, and the number of Buy ratings has risen from 18 of 30 three months earlier. Insiders have been sellers: sales totalled $123.9 million across recent filings over the last 18 months, with no open-market purchases. Such sales are often planned in advance or made to cover taxes on vesting shares, so they are a weaker signal than purchases would be.

The base case for the coming months is a range-bound stock that needs evidence of faster revenue growth before it can re-rate. Revenue grew 4.90% in the latest quarter against a sector median of 24.2%, and analysts expect revenue to rise 4.6% this fiscal year, so the valuation discount is unlikely to close without an acceleration. A move back above the 200-day SMA of $92.35 and the 20-day EMA of $93.69 would show the price repairing its trend. Failure to hold above the 52-week low of $70.70 would weaken the case considerably. The analysts' median 12-month target is $122.50, with a range from $79.00 to $135.00; those are forecasts, not guarantees. A simulation based on past volatility is not a forecast, and the stock's typical daily move of 2.35% means short-term swings are normal.

Support sits at the 52-week low of $70.70, the lowest price in the past year and the level a further decline would meet first. Resistance begins at the 200-day SMA of $92.35, which the price is just below and which a rise would meet first. Above it, the 20-day EMA of $93.69 and the 50-day SMA of $94.25 cluster closely together and would form a combined hurdle.